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In June, 2016, the new 2015 Journal Impact Factors (IF) were released, which is based on papers 
published in 2013 and 2014 and citations during 2015.  As noted in Table 1, the IF for Progress 
in Cardiovascular Diseases (PCVD) increased from the mid 2's the prior two years to now 4.635, 
increasing the PCVD rankings from 55th of 123 cardiovascular (CV) Journals in 2014 to now 
21st of 124 CV Journals.  This is the first time since 2011 that PCVD has been back in the Top 
25 list of CV Journals (Table 2).  If I were a Division 1 College Football Coach, getting into the 
Top 25 would usually mean a major increase in salary and being recruited to take over other 
major college programs, who would love to also make the Top 25 list.  As Editor in Chief (EIC) 
of a CV Journal, however, without the "raise" or recruitments, I can still take pride that PCVD is 
on solid ground. 
 
Many EICs focus heavily, maybe too much so, on the IF as this is the typical gauge to evaluate 
the status of one's Journal.  However, it should be kept in mind that changing the IF is a very 
slow process, and papers that are being published currently in 2016 will not even count for the IF 
until they are cited in either 2017 or 2018, and these IF's come out in mid year 2018 and 2019, 
respectively.  Also, the IF is only one parameter to judge a Journal's success.  Obviously, 
readership is also an extremely important parameter.  If a Journal focused too much on having 
very research oriented papers that may be cited by authors publishing on a particular topic, it is 
quite possible that the IF may increase, but the Journal may become less attractive to many non-
researchers/clinicians who like to read the clinical content to help them in their clinical practices.  
Several years ago, the EIC of the Mayo Clinic Proceedings (MCP), Dr. William "Bill" Lanier, 
wrote that it is often difficult to increase both the IF and Readership of a journal at the same 
time, but at MCP, where I have also served with Dr. Lanier as Associate Editor and CV Section 
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Editor for many years, we have done both.
1
  Certainly, this is a goal for me as EIC of PCVD as 
well, although one that is not easily accomplished. There are other parameters used to judge a  
Journal’s success, including article downloads, visits to the Website, media coverage, Social 
Media hits, etc, as well as the Eigenfactor and Article Influence Scores. Fortunately, the 
Publisher of PCVD, Elsevier, who publishes many leading Journals, including the MCP and 
many in CV diseases (all the JACC Journals, for example), has not placed any emphasis on my 
improving the IF, so I must admit that this is all self-imposed in my case. 
 
Also, for a journal like PCVD, which is currently published only six times yearly and typically 
has 10-12 major papers in each issue (or approximately 65-70 each year), this means that the IF 
is computed using only 130-140 papers during a 2-year cycle, meaning that just a few papers that 
are highly cited can tremendously effect the IF.  In this regard, my very first issue in 2014 on 
Obesity and the Obesity Paradox,
 2 
 10 of the all-time top 25 cited articles in PCVD's history 
came from this one issue.
3-12
  Although this suggests that the next IF will also be quite high, only 
one of the top 25 papers came from 2015,
13
 suggesting that the 2017 IF may not be nearly as 
high as the 2015 and 2016 ones. However, I still have hope for several other papers in 2015 and 
certainly 2016, especially in the January 2015 Physical Activity Issue, Guest Edited  by Drs. 
Ross Arena and JP Després .
14-19
  Four papers from my 2011 Exercise Issue ,which I Guest 
Edited for then EIC, Dr. Henry Greenberg, are also on this Top 25 list,
 20-23 
 which is one of the 
reasons that we will do another Exercise Issue ( Exercise Training in Health and Disease) in 
July/August 2017, which I will Guest Edit along with Dr. Ulrik Wisloff from Norway. Many of 
my colleagues and I also feel that physical inactivity is one of the greatest threats to health in the 
21st Century, and increasing awareness on this topic is also extremely important and also of high 
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interest to Specialists in CV Diseases , as well as to many clinicians and scientists outside of the 
usual PCVD readership. 
 
Regardless of the IF, however, with the support of my excellent team at Elsevier ( especially Ms 
Joan Anuels and Ms Rhosan Sotomayor), my Associate Editors, Drs. Christopher White and 
Hector Ventura, my lead assistant, Lisa Bienvenu, B.S., R.D.C.S., and my excellent Guest 
Editors, Editorial Board and Authors, I believe that the PCVD readership will continue to see an 
excellent and improving overall product over many years. 
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Table 1.  Progress in Cardiovascular Disease Journal Rankings. 
 
 
 
Year Impact Factor Rank of CV 
Journals 
2015 4.635 21/124 
2014 2.418 55/123 
2013 2.443 57/125 
2012 4.0 28/122 
2011 4.931 18/117 
 
 
CV = Cardiovascular   
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Table 2.  Top 25 Cardiovascular Journals Impact Factor Ratings. 
 
JOURNAL IMPACT 
FACTOR 
1. Journal of the American College of Cardiology 17.759 
2. Circulation 17.047 
3. European Heart Journal 15.064 
4. Circulation Research 11.551 
5. Nature Reviews Cardiology 10.533 
6. JACC-Cardiovascular Imaging 7.815 
7. JACC-Cardiovascular Interventions 7.63 
8. Journal of Heart And Lung Transplantation 7.509 
9. JACC-Heart Failure 7.218 
10. Circulation-Heart Failure 6.833 
11. Basic Research in Cardiology 6.008 
12. Journal of Cardiovascular Magnetic Resonance 5.752 
13. Circulation-Cardiovascular Imaging 5.744 
14. Circulation-Cardiovascular Interventions 5.706 
15. Heart 5.693 
16. Cardiovascular Research 5.465 
17. European Journal of Heart Failure 5.135 
18. Journal of the American Heart Association 5.117 
19. Journal of Molecular and Cellular Cardiology 4.874 
20. International Journal of Cardiology 4.638 
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21. Progress in Cardiovascular Diseases 4.635 
22. Revista Espanola De Cardiologia 4.596 
23. Cardiovascular Diabetology 4.534 
24. Circulation-Arrhythmia and Electrophysiology 4.428 
25. Heart Rhythm 4.391 
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